-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Twist Bioscience, Raises Price Target to $55

Benzinga·03/30/2026 15:21:46
Listen to the news
Guggenheim analyst Subbu Nambi maintains Twist Bioscience (NASDAQ:TWST) with a Buy and raises the price target from $50 to $55.